Posted on October 12th, 2010 by Health News
Women who have estrogen (ER)-negative breast cancer may have more drug-treatment options than previously thought, a Creighton (pronounced Cray-ton) University study suggests. The study is reported in the Oct. 11 online version of the journal Oncogene…
Read more
Filed under: Women's Health
Tags: Breast Cancer, cancer, Drug, Online, Women's Health
Related posts
- Mayo Collaboration Finds Source Of Breast Drug Side Effect (0)
Mayo Clinic researchers and their international colleagues have discovered genetic variants that lead to severe arthritis for a subset of women when taking aromatase inhibitors to treat their breast cancer. This serious side effect is so painful that many women halt their lifesaving medication. The findings appear in the online issue of Journal of Clinical [...]
- Women’s Health Policy Report Highlights Studies From Recent Breast Cancer Conference (0)
The following summarizes findings reported last week at the San Antonio Breast Cancer Symposium. ~ Anthracyclines: New research suggests that anthracyclines -- a class of chemotherapy drugs commonly used to treat breast cancer -- could cause more harm than benefits for breast cancer patients because they can be damaging to the heart, the Wall Street [...]
- Women With Breast Implants Encouraged To Go Beyond Regular Mammogram Screening (0)
NewImage.com, the premier online destination for personal image enhancement solutions, is pleased to support National Breast Cancer Awareness Month for a second year by helping raise awareness of the importance of early detection and encouraging women with breast implants to go beyond regular mammography screenings to reduce the risk of possibly missing a tumor hidden [...]
- Vitamin D Relieves Joint, Muscle Pain For Breast Cancer Patients (0)
High-dose vitamin D relieves joint and muscle pain for many breast cancer patients taking estrogen-lowering drugs, according to a new study from Washington University School of Medicine in St. Louis. The drugs, known as aromatase inhibitors, are commonly prescribed to shrink breast tumors fueled by the hormone estrogen and help prevent cancer recurrence...
Read more
[tags] Women's [...]
- Use Of Costly Breast Cancer Therapy Strongly Influenced By Reimbursement Policy (0)
What Medicare would pay for and where a radiation oncologist practiced were two factors that strongly influenced the choice of intensity-modulated radiation therapy (IMRT) for treating breast cancer, according to an article published April 29 online in the Journal of the National Cancer Institute. The use of IMRT and the cost of radiation therapy increased [...]
Leave a Reply